Bridion® injection now approved for patients of all ages
Merck Sharp & Dohme LLC has submitted supplemental new drug application which was received on June 12, 2024 by FDA
A forum for researchers, students and applicants in the field of cyclodextrin technology
Merck Sharp & Dohme LLC has submitted supplemental new drug application which was received on June 12, 2024 by FDA
A recent poster by R.E. Williams and C. M. Marshall, (Jon Njardarson’s group, University of Arizona) listed the Top 200
Merck / MSD has released an announcement on 13 June, 2023 that the U.S. District Court for the District of